Only $35.99/year

Terms in this set (20)

Control progression:

1.General lifestyle and diet modification
*Intermediate atrophic AMD may benefit from AREDS II
Vitamin C (500 mg)
Vitamin E (400 International unit)
Zinc (80mg as zinc oxide)
Copper (2mg as copper oxide)
Lutein (10mg)
Zeaxanthin (2mg)
*Increase intake of green leafy vegetable + 1 serve of fish every week
*Smoking cessation is ideal
*Control Hypertension

2.Home monitoring (Amsler Grid) and beware of neovascular AMD symptoms (acute distortion, central vision loss)
*OPHTHALMOLOGIST REFERRAL within 1 week

Visual needs:

3.Low vision aids/visual enhancement devices (Reading add, magnifiers with reading/spotting tasks, telescopes)
4.Glare management (sunglasses, avoid glossy surfaces, modify light sources)
5.Driving standard
*Private VA > 6/12 one eye, Commercial better eye >6/9 and worse eye >6/18 (conditional or unconditional upon wearing corrective lenses)
*Visual field: 110 horizontal and 20 vertically (Esterman Binocular Visual Field), a cluster of no more than 3 points within central 20 degrees

Social support:

6.Referral to patient support services (Vision Australia or Guide Dogs Australia)
*Orientation and mobility training
*Welfare and counselling (eligibility for support pension, concession)
*Electronic Vision Enhancement Systems
*Education and Employment service

7.Counsel Charles-Bonnet syndrome



REVIEW: YEARLY (6 MONTHS for INTERMEDIATE OR LATE ATROPHIC AMD)

NEOVASCULAR AMD Anti-VEGF therapy
Avastin (bevacizumab) - PBS not approved
Lucentis (ranibizumab) - PBS approved
Dosing: Likely monthly for 3 months or until improvement